Substitution or deletion mutations between nt 54 and 70 in the 5′ non-coding region of dengue type 2 virus produce variable effects on virus viability
Authors:
- 1 June 2007
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 88 (6) , 1748-1752
Abstract
A C57U nucleotide mutation in a predicted RNA stem structure (nt 11–16/56–61) of the 5′ non-coding region (5′NCR) of dengue 2 (DEN-2) 16681 virus is partially attenuating, but unstable during serial passage of certain candidate DEN-2 PDK-53-based vaccine viruses containing this mutation. Here, 11 different mutations (one or more point substitution and/or deletion) between nt 54 and 70 in the 5′NCR of the pD2/IC-30P-A (16681) infectious clone are described. Four mutants were infectious. Three mutants with single point substitutions replicated well in cell culture and exhibited variable neurovirulence in mice. Constructs containing multiple substitutions or any deletions failed to produce infectious viruses. Unexpectedly, a double C57U+G58C mutant replicated as efficiently as D2/IC-30P-A virus, and was more neurovirulent for newborn ICR mice. Thus, despite its predicted additional disruption of the RNA stem structure, the engineered contiguous secondary G58C mutation caused reversion of the partially attenuated phenotype caused by the 5′NCR-C57U mutation.Keywords
This publication has 19 references indexed in Scilit:
- A 5′ RNA element promotes dengue virus RNA synthesis on a circular genomeGenes & Development, 2006
- Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMAJournal of Virological Methods, 2006
- Long-Range RNA-RNA Interactions Circularize the Dengue Virus GenomeJournal of Virology, 2005
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentJournal of Virology, 2003
- Sequences in the 5′ Leader of Mason-Pfizer Monkey Virus Which Affect Viral Particle Production and Genomic RNA Packaging: Development of MPMV Packaging Cell LinesVirology, 2001
- Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the 5′ Noncoding Region and Nonstructural Proteins 1 and 3Journal of Virology, 2000
- Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus VaccineJournal of Virology, 2000
- Resurgent Vector-Borne Diseases as a Global Health ProblemEmerging Infectious Diseases, 1998
- Growth-Restricted Dengue Virus Mutants Containing Deletions in the 5′ Noncoding Region of the RNA GenomeVirology, 1995
- Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNAVirology, 1988